Market cap
₹29 Cr
Revenue (TTM)
₹33 Cr
P/E Ratio
7.1
P/B Ratio
0.9
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹2 Cr
-
ROE
12.3 %
-
ROCE
10.3 %
-
Industry P/E
48.43
-
EV/EBITDA
3.1
-
Debt to Equity
0.7
-
Book Value
₹38
-
EPS
₹4.7
-
Face value
10
-
Shares outstanding
8,582,400
6 Years Aggregate
CFO
₹-11.91 Cr
EBITDA
₹8.37 Cr
Net Profit
₹5.26 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
SUNREST
| -8.6 | -15.9 | -8.1 | -24.0 | -- | -- | -- |
|
BSE Healthcare
| 9.1 | 1.2 | 7.9 | 7.7 | 25.1 | 13.2 | 12.3 |
|
Company
|
2025
|
2024
|
|---|---|---|
|
SUNREST
| -19.3 | -18.4 |
|
BSE Small Cap
| -6.6 | 29.0 |
|
BSE Healthcare
| -3.3 | 43.1 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
SUNREST
|
33.9 | 29.1 | 33.4 | 2.0 | -- | 12.3 | 7.1 | 0.9 |
| 1,045.7 | 12,850.2 | 2,551.8 | 564.5 | 28.3 | 18.4 | 22.8 | 3.9 | |
| 512.5 | 8,892.7 | 947.3 | 247.8 | 28.5 | 18.9 | 35.9 | 6.5 | |
| 1,353.8 | 14,163.5 | 1,054.9 | 256.3 | 27.8 | 13.7 | 54.3 | 7.0 | |
| 1,736.2 | 32,891.7 | 9,203.5 | 941.3 | 15.4 | 19.6 | 35.6 | 6.6 | |
| 17,198.0 | 22,038.5 | 2,023.0 | 364.0 | 23.9 | 20.8 | 60.5 | 11.8 | |
| 917.1 | 4,650.9 | 811.3 | 21.0 | 0.7 | 2.1 | 226.4 | 3.6 | |
| 1,290.0 | 5,946.7 | 649.5 | 121.6 | 23.7 | 13.2 | 51.5 | 6.4 | |
| 749.5 | 8,465.5 | 502.0 | 138.7 | -- | 32.8 | 49 | 9.6 | |
| 268.3 | 7,083.5 | 7.1 | -276.3 | -4,077.5 | -63.3 | -- | 12.0 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About SUNREST
Manufacture of pharmaceuticals, medicinal chemical and botanical products
-
Incorporated
2017
-
Chairman
Juhi Sawajani
-
Managing Director
Nikhilkumar Y Thakkar
-
Headquarters
Ahmedabad, Gujarat
-
Website
Looking for more details about Sunrest Lifescience Ltd’s IPO? Explore our IPO Details page.
FAQs for SUNREST
What is the current share price of Sunrest Lifescience Ltd Today?
The share price of Sunrest Lifescience Ltd is ₹33.90 (NSE) as of 12-Jun-2026 IST. Sunrest Lifescience Ltd has given a return of -24.02% in the last 1 years.
What is the current PB & PE ratio of Sunrest Lifescience Ltd?
The P/E ratio of Sunrest Lifescience Ltd is 7.07 times as on 12-Jun-2026, a 85 discount to its peers’ median range of 48.43 times.
The P/B ratio of Sunrest Lifescience Ltd is 0.93 times as on 12-Jun-2026, a 82 discount to its peers’ median range of 5.11 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
11.50
|
1.26
|
|
2024
|
116.07
|
1.65
|
|
2023
|
0.00
|
0.00
|
|
2022
|
0.00
|
0.00
|
|
2021
|
0.00
|
0.00
|
What is the 52 Week High and Low of Sunrest Lifescience Ltd?
The 52-week high and low of Sunrest Lifescience Ltd are Rs 54.43 and Rs 26.37 as of 13-Jun-2026.
What is the market cap of Sunrest Lifescience Ltd?
Sunrest Lifescience Ltd has a market capitalisation of ₹ 29 Cr as on 12-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Sunrest Lifescience Ltd?
Before investing in Sunrest Lifescience Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.